NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









IMVARIA Inc.

IMVARIA Inc.

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://imvaria.com/

Last Round

Strategic

Jan 7, 2026

Company Overview

IMVARIA Inc. is a healthcare technology company that develops artificial intelligence-driven digital biomarker solutions for the non-invasive diagnosis and assessment of interstitial lung diseases and idiopathic pulmonary fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIsoftware as a medical deviceSaMDdigital biomarkerpulmonary diagnosticsmedical imaging AIinterstitial lung diseaseILDclinical decision supportAI diagnosticsradiology AInon-invasive diagnosisidiopathic pulmonary fibrosisIPFhealth techAI-in-a-box

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IMVARIA Inc. Comparables

Compare IMVARIA Inc. with similar companies based on industry and business-model similarity.

IMVARIA Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

IMVARIA Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 7, 2026
GrantSep 3, 2025
AcceleratorJun 15, 2021
AcceleratorJun 10, 2021

Key People

Founding team and executive leadership

Michael C. Muelly

Founder & CTO

Founding Team

Joshua Reicher

Co-Founder And CEO

Founding Team

IMVARIA Inc. Investors

Notable investors and investment history

IMVARIA Inc. investors
InvestorRounds
UCSF Rosenman InstituteAccelerator
MedTech InnovatorAccelerator
NIH RADxGrant
Inhealth VenturesStrategic
Cedar Crest CapitalStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2025

    Presented AI diagnostic referral service results at ATS 2025.

IMVARIA Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IMVARIA Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IMVARIA Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range9
Year Founded2019
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.